RemeGen Co Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Please join me in welcoming Dr. Fang Jianmin, Co-Founder, CEO and CSO of RemeGen, for his roadshow presentation on the topic of RemeGen focusing on innovative Biologics for unmet medical need.
My name is Jianmin Fang. I am the Founder, CEO, CSO of RemeGen (foreign language). Remegen is -- just first will give an overview about Remegen. Remegen was founded in 2008. Currently we have over 1,000 employees. We are headquartered in Yantai in China with an R&D facility in Shanghai and also in South San Francisco, California. Also we have a regulatory clinical office in Beijing and Washington DC.
We are dedicated to the discovery, development, manufacturing and the commercialization of innovative biologics to address global medical need for unmet medical need. So our innovation -- we are focused on autoimmune disease, oncologic and ophthalmic disease. And currently we have two innovative biologics, RC18 and RC48, filed the NDA or BLA in China, so ready for commercialization.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |